151. Rasmussen encephalitis Clinical trials / Disease details


Clinical trial : 1 Drugs : 2 - (DrugBank : 1) / Drug target genes : 5 - Drug target pathways : 33

  
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT00545493
(ClinicalTrials.gov)
November 200216/10/2007Efficacy of Tacrolimus and I.V.-Immunoglobulins in Rasmussen EncephalitisEfficacy of Tacrolimus and i.v.-Immunoglobulins in Rasmussen Encephalitis With Start of Treatment in the Acute Disease Stage. Prospective, Randomised, Open Parallel Group StudyRasmussen EncephalitisDrug: Tacrolimus;Drug: i.v. immunoglobulinsUniversity Hospital, BonnOctapharma;Astellas Pharma GmbHActive, not recruitingN/AN/ABoth16Phase 2/Phase 3Germany